Item 4. Controls and Procedures
5K characters. Original on sec.gov ·
Item 4. Controls and Procedures
Evaluation of Disclosure Controls and Procedures
Management has evaluated the effectiveness of the design and operation of the disclosure controls and procedures as defined in Securities Exchange Act Rule 13a-15(e) as of September 30, 2026. Based on that evaluation, the Chief Executive Officer and the Chief Financial Officer have concluded that these disclosure controls and procedures were effective as of such date at the level of providing reasonable assurance.
In designing and evaluating our disclosure controls and procedures, management, including the Chief Executive Officer and the Chief Financial Officer, recognized that any controls and procedures, no matter how well designed and operated, can provide only reasonable assurance of achieving the desired control objectives, and management necessarily was required to apply its judgment in evaluating the cost-benefit relationship of possible controls and procedures.
Because of the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within the Company have been detected.
Changes in Internal Control over Financial Reporting
There were no changes in our internal control over financial reporting during our most recently completed fiscal quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
| 41 |
CRH FORM 10-Q
PART II - OTHER INFORMATION
Item 1. Legal Proceedings
The Company is from time to time a party to various legal proceedings that arise in the ordinary course of business. We do not believe any pending legal proceeding to which the Company is a party will have a material effect on our financial condition, results of operations or liquidity.
1A. Risk Factors
There have been no material changes with respect to the risk factors disclosed in 'Item 1A. Risk Factors' of our 2025 Form 10-K and our other filings with the SEC.
Item 2. Unregistered Sales of Equity Securities, Use of Proceeds, and Issuer Purchases of Equity Securities
The following table presents the number and average price of shares purchased in each month of the third quarter of 2026:
| Period | (a) Total Number of Shares Purchased | (b) Average Price Paid per Share | (c) Total Number of Shares Purchased as Part of Publicly Announced Plans or Programs (i) | (d) Approximate Dollar Value of Shares that May Yet Be Purchased Under the Plans or Programs | ||||||||||
| July 1 – July 31, 2026 | 802,429 | $103.94 | 802,429 | $— | ||||||||||
| August 1 – August 31, 2026 | – | $— | – | $— | ||||||||||
| September 1 – September 30, 2026 | – | $— | – | $— | ||||||||||
| Total | 802,429 | 802,429 |
(i) In May 2018, CRH announced its intention to introduce a share repurchase program to repurchase Ordinary Shares (the "Program"). In the third quarter of 2026, the Company returned a further $0.1 billion of cash to shareholders through the repurchase of 802,429 Ordinary Shares (equivalent to 0.1% of the Company’s issued and outstanding Ordinary Shares as of September 30, 2026). This brought total cash returned to shareholders under the legacy program to $10.3 billion since its commencement in May 2018.
The purchases in the third quarter of 2026 were completed under the following tranche:
| Date Announced | Max Amount to be Repurchased (in $ millions) | Termination Date | |||||||||
| April 30, 2026 | (Tranche 29) | 300 | July 28, 2026 |
On October 29, 2026, the Company announced that its Board of Directors authorized a new share buyback program of up to $6 billion (the "New Program"), expiring at the end of 2030. No repurchases have been made under the New Program as of the date of this Quarterly Report.
Item 3. Defaults Upon Senior Securities
None.
Item 4. Mine Safety Disclosures
The information concerning mine safety violations or other regulatory matters required by Section 1503(a) of the Dodd‐Frank Wall Street Reform and Consumer Protection Act and Item 104 of Regulation S‐K (17 CFR 229.104) is included in Exhibit 95.1 to this Quarterly Report.
Previous: Item 3. Quantitative and Qualitative Disclosures About Market Risk · Next: Item 5. Other Information